$40.11
3M Ago | 1M Ago | Current | |
Buy | 10 | 10 | 10 |
Outperform | 8 | 9 | 9 |
Hold | 5 | 4 | 4 |
Underperform | 0 | 0 | 0 |
Sell | 0 | 0 | 0 |
The latest share price target for Apellis Pharmaceuticals Inc (APLS) is $77.44, offered by 23 analysts offering 12-month price forecasts.
Apellis Pharmaceuticals Inc (APLS) has a maximum of 0.93 upside potential, based on 23 analysts offering 12-month price forecasts.
Based on 23 analysts tracking and researching Apellis Pharmaceuticals Inc (APLS), 82.61% have a buy recommendation. Remaining 17.39% have either sell or hold recommendations.
The latest share price of Apellis Pharmaceuticals Inc (APLS) is $40.11 as of 04/06/2024.
19 of total 23 analysts offering stock ratings for Apellis Pharmaceuticals Inc APLS have recommended buy rating.